Tag:

Novartis

Novartis, Roche back US push to cut prescription drug costs

Swiss pharmaceutical giants Novartis and Roche have expressed support for U.S. efforts to lower drug prices and are working with the Trump administration on potential pricing agreements. The discussions follow a trend of recent deals by Pfizer, AstraZeneca, Eli Lilly, and Novo Nordisk to reduce costs for Medicare, Medicaid, and cash-paying patients.

18 Dec 2025-13:35
Novartis forecasts 5%-6% annual sales growth through 2030 driven by key cancer drugs

Swiss pharmaceutical giant Novartis AG expects currency-adjusted annual sales growth of 5% to 6% until 2030, driven largely by stronger-than-anticipated revenue from its leading cancer therapies, Kisqali and Scemblix.

20 Nov 2025-10:39
First malaria drug approved for babies in major public health breakthrough

The world’s first malaria treatment specifically designed for newborns and young babies has been approved for use and is set to be rolled out across African countries within weeks, marking a critical advance in the fight against one of the world's deadliest diseases.

08 Jul 2025-09:48